Ocular Therapeutix™ Reports Second Quarter 2018 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Ocular Therapeutix (OCUL) Tops Q2 EPS by 1c
August 7, 2018 4:01 PM EDTOcular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.37), $0.01 better than the analyst estimate of ($0.38).
We are encouraged with our progress through the first half of 2018, said Antony Mattessich, President and Chief Executive Officer. The on-time resubmission and establishment of a December 28th PDUFA date for... More
